Metabolomic Biomarkers of Prostate Cancer: Prediction, Diagnosis, Progression, Prognosis, and Recurrence
Metabolite profiling is being increasing employed in the study of prostate cancer as a means of identifying predictive, diagnostic, and prognostic biomarkers. This review provides a summary and critique of the current literature. Thirty-three human case-control studies of prostate cancer exploring d...
Main Authors: | Kelly, R. S., Giovannucci, E., Mucci, L. A., Vander Heiden, Matthew G. |
---|---|
Other Authors: | Koch Institute for Integrative Cancer Research at MIT |
Format: | Article |
Published: |
American Association for Cancer Research (AACR)
2018
|
Online Access: | http://hdl.handle.net/1721.1/116917 https://orcid.org/0000-0002-6702-4192 |
Similar Items
-
Metabolomic Biomarkers for Detection, Prognosis and Identifying Recurrence in Endometrial Cancer
by: Kelechi Njoku, et al.
Published: (2020-07-01) -
Tissue metabolomics identified new biomarkers for the diagnosis and prognosis prediction of pancreatic cancer
by: Chang Liu, et al.
Published: (2022-09-01) -
High-resolution metabolomic biomarkers for lung cancer diagnosis and prognosis
by: Shi-ang Qi, et al.
Published: (2021-06-01) -
A Metabolomics Analysis of Adiposity and Advanced Prostate Cancer Risk in the Health Professionals Follow-Up Study
by: Dickerman, Barbra A., et al.
Published: (2020) -
A Metabolomics Analysis of Adiposity and Advanced Prostate Cancer Risk in the Health Professionals Follow-Up Study
by: Barbra A. Dickerman, et al.
Published: (2020-03-01)